The overexpression of CXCR4 in multiple cancer types and its pivotal role in tumour progression via the CXCR4/CXC12 axis makes this chemokine receptor an attractive target for cancer diagnosis, response assessment and patient profiling [114]. This evidence concerns the gene CXCR4 and cancer.